Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Wnt signaling pathway (mmu04310)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
1500003O
03Rik
KLA  ATP  ATP+KLA
 NM_019769 RIKEN cDNA 1500003O03 gene (1500003O03Rik), mRNA [NM_019769] KLA .92 .89 .89 .86 .85 .92 1.08
ATP 1.01 1.16 1.16 1.53 1.70 3.33 2.09
KLA/ATP .89 .97 .93 1.17 1.19 2.86 2.57
2010110P
09Rik
KLA  ATP  ATP+KLA
 NM_027363 RIKEN cDNA 2010110P09 gene (2010110P09Rik), mRNA [NM_027363] KLA .99 .98 1.02 .99 .94 1.01 1.01
ATP 1.04 1.05 .97 1.05 .95 .98 .95
KLA/ATP .93 1.00 1.02 .97 1.01 .96 .97
4930444G
20Rik
KLA  ATP  ATP+KLA
 NM_053264 RIKEN cDNA 4930444G20 gene (4930444G20Rik), mRNA [NM_053264] KLA 1.01 1.00 .98 .92 .90 .97 1.01
ATP 1.06 1.03 .96 1.08 .99 1.00 .98
KLA/ATP 1.11 1.04 1.00 1.05 .92 .97 1.04
AF366264
KLA  ATP  ATP+KLA
 NM_153093 cDNA sequence AF366264 (AF366264), mRNA [NM_153093] KLA 1.11 1.05 1.04 1.04 1.06 1.10 1.04
ATP 1.19 1.18 1.15 1.14 1.00 1.15 1.05
KLA/ATP 1.44 1.36 1.49 1.38 1.09 1.31 1.23
AK019932
KLA  ATP  ATP+KLA
 AK019932 adult male pituitary gland cDNA, RIKEN full-length enriched library, clone:5330434N09 product:inferred: transmembrane receptor frizzled 5 {Mus musculus}, full insert sequence [AK019932] KLA .99 .94 .97 .98 .96 .99 1.03
ATP 1.02 1.07 1.02 .97 1.00 .98 .93
KLA/ATP .93 .99 .91 1.04 1.02 1.01 1.00
AK036998
KLA  ATP  ATP+KLA
 AK036998 adult female vagina cDNA, RIKEN full-length enriched library, clone:9930034M05 product:unclassifiable, full insert sequence. [AK036998] KLA 1.43 1.09 .89 .79 .96 .97 .71
ATP 1.04 1.04 .71 .64 .90 .82 .82
KLA/ATP 1.34 1.23 1.01 .89 1.10 .82 .75
Apc
KLA  ATP  ATP+KLA
 NM_007462 adenomatosis polyposis coli (Apc), mRNA [NM_007462] KLA .98 .94 .91 .86 .83 .91 1.01
ATP 1.06 1.16 1.04 .97 1.63 1.50 1.25
KLA/ATP 1.01 1.01 .92 .88 1.22 1.46 1.21
Apc2
KLA  ATP  ATP+KLA
 NM_011789 adenomatosis polyposis coli 2 (Apc2), mRNA [NM_011789] KLA 1.05 1.15 1.12 1.13 1.07 1.11 1.08
ATP 1.04 .97 1.15 1.27 1.12 1.09 1.16
KLA/ATP 1.12 1.20 1.21 1.24 1.25 1.13 1.04
Axin1
KLA  ATP  ATP+KLA
 NM_009733 axin 1 (Axin1), mRNA [NM_009733] KLA .97 .91 1.14 1.08 1.23 1.21 1.07
ATP 1.08 1.06 .96 1.04 1.56 1.30 1.13
KLA/ATP 1.05 1.03 1.06 1.03 1.43 1.45 1.21
Axin2
KLA  ATP  ATP+KLA
 NM_015732 axin2 (Axin2), mRNA [NM_015732] KLA .91 .97 1.00 .97 1.00 .97 1.00
ATP .99 .97 .97 1.04 1.12 .98 1.01
KLA/ATP .98 .86 1.25 1.04 1.09 1.01 1.06
Bambi
KLA  ATP  ATP+KLA
 NM_026505 BMP and activin membrane-bound inhibitor, homolog (Xenopus laevis) (Bambi), mRNA [NM_026505] KLA 1.52 1.41 1.12 .61 .61 1.26 .84
ATP 1.33 1.93 2.43 2.79 2.83 2.18 1.24
KLA/ATP 1.52 1.79 2.51 2.89 3.90 4.00 1.23
BB113440
KLA  ATP  ATP+KLA
 BB113440 gb|BB113440 RIKEN full-length enriched, adult male urinary bladder Mus musculus cDNA clone 9530041B19 3. [BB113440] KLA .94 .95 .94 .95 1.05 .99 1.05
ATP 1.03 1.07 1.79 1.71 1.51 1.12 1.06
KLA/ATP .95 1.11 1.27 1.15 1.05 1.14 1.25
BI646741
KLA  ATP  ATP+KLA
 BI646741 gb|BI646741 603279769F1 NCI_CGAP_Mam3 Mus musculus cDNA clone IMAGE:5320025 5, mRNA sequence [BI646741] KLA .55 .54 .47 .54 .65 1.09 1.60
ATP 1.04 .99 .93 1.08 2.49 .79 .88
KLA/ATP .54 .49 .54 .60 1.21 .97 1.54
Btrc
KLA  ATP  ATP+KLA
 NM_009771 beta-transducin repeat containing protein (Btrc), transcript variant 2, mRNA [NM_009771] KLA 1.30 1.33 1.62 1.50 1.93 1.79 1.60
ATP 1.07 1.30 1.05 1.26 .67 .99 1.56
KLA/ATP 1.40 1.61 1.13 1.72 .88 1.50 1.97
C030016K
15Rik
KLA  ATP  ATP+KLA
 AK021086 adult male corpus striatum cDNA, RIKEN full-length enriched library, clone:C030016K15 product:unclassifiable, full insert sequence. [AK021086] KLA .91 .86 .85 .85 .75 .85 .85
ATP .98 .92 .92 .89 .68 .75 1.16
KLA/ATP .83 .82 .81 .76 .72 .69 .66
Cacybp
KLA  ATP  ATP+KLA
 NM_009786 calcyclin binding protein (Cacybp), mRNA [NM_009786] KLA 2.10 2.34 2.32 2.21 2.00 1.86 1.61
ATP .95 .99 1.01 .81 1.14 1.52 .87
KLA/ATP 1.99 2.03 2.17 1.77 2.13 1.57 .84
Camk2a
KLA  ATP  ATP+KLA
 NM_177407 calcium/calmodulin-dependent protein kinase II alpha (Camk2a), transcript variant 2, mRNA [NM_177407] KLA .98 .97 .98 .95 .97 1.02 .97
ATP .98 1.11 1.02 .89 .94 .89 .82
KLA/ATP .99 .95 1.02 .88 .88 .87 .87
Camk2b
KLA  ATP  ATP+KLA
 NM_007595 calcium/calmodulin-dependent protein kinase II, beta (Camk2b), mRNA [NM_007595] KLA 1.09 1.28 1.42 1.41 1.37 1.24 .68
ATP .94 .87 .95 .91 .67 .44 .48
KLA/ATP 1.16 1.24 1.40 1.13 1.14 .81 .49
Camk2d
KLA  ATP  ATP+KLA
 AK032524 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430579P05 product:calcium/calmodulin-dependent protein kinase II, delta, full insert sequence. [AK032524] KLA 1.31 1.45 1.42 1.21 1.34 1.18 1.16
ATP 1.04 1.29 1.39 1.24 .94 .91 1.22
KLA/ATP 1.46 1.64 1.42 1.24 1.00 .93 1.10
Camk2d
KLA  ATP  ATP+KLA
 NM_001025439 calcium/calmodulin-dependent protein kinase II, delta (Camk2d), transcript variant 1, mRNA [NM_001025439] KLA 1.76 1.75 1.72 1.89 1.47 1.55 1.24
ATP 1.06 1.06 .93 1.01 1.22 .98 2.28
KLA/ATP 1.84 1.78 1.40 1.57 1.07 .60 1.97
Camk2g
KLA  ATP  ATP+KLA
 NM_178597 calcium/calmodulin-dependent protein kinase II gamma (Camk2g), transcript variant 1, mRNA [NM_178597] KLA .23 .24 .23 .44 .70 .73 .70
ATP .91 .85 1.07 .86 .58 .59 .95
KLA/ATP .22 .20 .35 .25 .54 .59 .71
Ccnd1
KLA  ATP  ATP+KLA
 S78355 gb|Cyl-1=cyclin D1 [mice, BALB/c, brain, mRNA, 3737 nt]. [S78355] KLA .24 .23 .23 .24 .29 .47 .17
ATP 1.02 1.02 .88 .80 .52 .10 .21
KLA/ATP .27 .23 .22 .24 .27 .25 .14
Ccnd2
KLA  ATP  ATP+KLA
 NM_009829 cyclin D2 (Ccnd2), mRNA [NM_009829] KLA 12.92 13.66 11.94 12.37 11.11 5.44 1.53
ATP .98 .75 .50 .57 1.24 2.83 .40
KLA/ATP 11.19 11.62 10.34 7.96 7.92 7.10 2.57
Ccnd3
KLA  ATP  ATP+KLA
 NM_007632 cyclin D3 (Ccnd3), transcript variant 1, mRNA [NM_007632] KLA .60 .65 .86 1.02 1.91 2.26 1.45
ATP 1.05 1.14 .89 1.20 .74 .76 .99
KLA/ATP .70 .67 .54 .83 .61 1.19 1.45
Cer1
KLA  ATP  ATP+KLA
 NM_009887 cerberus 1 homolog (Xenopus laevis) (Cer1), mRNA [NM_009887] KLA .99 .98 .96 .96 1.01 1.00 1.05
ATP .95 .99 .99 1.04 1.04 1.00 1.02
KLA/ATP .94 1.02 1.02 1.09 .98 1.00 .98
Chd8
KLA  ATP  ATP+KLA
 BC023856 chromodomain helicase DNA binding protein 8, mRNA (cDNA clone IMAGE:5346758). [BC023856] KLA 1.02 1.08 1.13 1.01 1.30 1.16 1.12
ATP 1.02 1.12 .70 .66 1.10 1.07 1.02
KLA/ATP 1.18 1.09 .70 .81 1.26 1.17 1.01
Chd8
KLA  ATP  ATP+KLA
 NM_201637 chromodomain helicase DNA binding protein 8 (Chd8), mRNA [NM_201637] KLA 1.08 .94 1.00 1.08 1.18 1.16 .91
ATP .96 .90 .99 .63 .77 1.22 1.00
KLA/ATP .97 1.06 1.10 .61 .97 1.27 1.05
Crebbp
KLA  ATP  ATP+KLA
 AK048818 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230072N21 product:hypothetical protein, full insert sequence [AK048818] KLA 1.44 1.19 1.26 1.25 1.25 1.36 1.24
ATP .98 .90 1.04 1.11 1.95 2.72 1.51
KLA/ATP 1.17 1.27 1.45 1.28 1.98 2.80 2.52
Crebbp
KLA  ATP  ATP+KLA
 NM_001025432 CREB binding protein (Crebbp), mRNA [NM_001025432] KLA .97 1.01 .98 1.06 1.05 .99 1.07
ATP 1.07 1.05 .96 1.01 1.15 1.14 1.00
KLA/ATP 1.01 .97 .97 1.00 1.03 1.23 1.13
Crebbp
KLA  ATP  ATP+KLA
 S66385 gb|CREB-binding protein [mice, brain, mRNA Partial, 7326 nt]. [S66385] KLA 1.00 .98 1.08 .98 1.04 1.07 1.08
ATP .99 .98 .99 1.09 1.13 1.08 1.05
KLA/ATP 1.06 1.00 1.05 1.03 1.02 1.14 1.11
Csnk1a1
KLA  ATP  ATP+KLA
 AK017353 6 days neonate head cDNA, RIKEN full-length enriched library, clone:5430427P18 product:unclassifiable, full insert sequence. [AK017353] KLA 1.75 1.68 1.55 1.76 1.33 1.34 1.16
ATP .85 .76 .85 .50 .66 1.35 1.09
KLA/ATP 1.51 1.56 1.49 .72 .76 .86 1.02
Csnk1a1
KLA  ATP  ATP+KLA
 AK152387 bone marrow macrophage cDNA, RIKEN full-length enriched library, clone:I830067L20 product:casein kinase 1, alpha 1, full insert sequence [AK152387] KLA 1.58 1.39 1.32 1.47 1.46 1.42 1.06
ATP 1.07 1.05 1.31 1.40 1.63 1.57 1.34
KLA/ATP 1.54 1.51 2.07 1.98 2.12 2.22 1.90
Csnk1a1
KLA  ATP  ATP+KLA
 NM_146087 casein kinase 1, alpha 1 (Csnk1a1), mRNA [NM_146087] KLA 1.76 1.68 1.56 1.55 1.57 1.33 1.35
ATP 1.03 .86 .67 .60 .90 1.33 1.14
KLA/ATP 1.61 1.50 1.08 .92 1.02 1.46 1.87
Csnk1e
KLA  ATP  ATP+KLA
 NM_013767 casein kinase 1, epsilon (Csnk1e), mRNA [NM_013767] KLA .75 .69 .67 .71 .68 .64 .76
ATP .98 .89 .97 .94 1.80 .90 .83
KLA/ATP .68 .66 .70 .73 1.79 .84 .72
Csnk2a1
KLA  ATP  ATP+KLA
 NM_007788 casein kinase 2, alpha 1 polypeptide (Csnk2a1), mRNA [NM_007788] KLA 1.36 1.39 1.19 1.34 1.32 1.74 1.86
ATP .92 .88 1.13 .86 1.12 2.50 1.99
KLA/ATP 1.19 1.24 1.35 1.03 1.16 2.09 2.88
Csnk2a2
KLA  ATP  ATP+KLA
 NM_009974 casein kinase 2, alpha prime polypeptide (Csnk2a2), mRNA [NM_009974] KLA 1.46 1.53 1.70 1.47 1.32 1.32 1.17
ATP 1.00 1.11 1.17 1.33 1.71 2.03 1.06
KLA/ATP 1.58 1.67 1.69 2.00 2.20 2.44 1.68
Csnk2b
KLA  ATP  ATP+KLA
 NM_009975 casein kinase 2, beta polypeptide (Csnk2b), mRNA [NM_009975] KLA 1.19 1.10 1.12 1.13 1.20 1.28 1.25
ATP 1.12 1.03 1.04 1.07 1.20 1.27 1.09
KLA/ATP 1.15 1.20 1.25 1.13 1.44 1.34 1.35
Ctbp1
KLA  ATP  ATP+KLA
 NM_013502 C-terminal binding protein 1 (Ctbp1), mRNA [NM_013502] KLA .77 .77 .71 .65 .67 .65 .95
ATP .89 .84 .42 .45 .45 .71 .80
KLA/ATP .73 .65 .30 .34 .34 .64 .61
Ctbp2
KLA  ATP  ATP+KLA
 NM_009980 C-terminal binding protein 2 (Ctbp2), mRNA [NM_009980] KLA .59 .57 .49 .44 .44 .60 .85
ATP .91 .87 .75 .79 .72 .89 .96
KLA/ATP .60 .50 .41 .45 .54 .63 .71
Ctnnb1
KLA  ATP  ATP+KLA
 AK020013 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830416C23 product:catenin beta, full insert sequence. [AK020013] KLA 1.06 1.15 1.00 1.06 1.27 1.14 1.03
ATP .85 .57 1.74 3.36 4.13 2.19 1.55
KLA/ATP 1.12 .87 2.47 3.61 3.79 2.21 2.06
Ctnnb1
KLA  ATP  ATP+KLA
 NM_007614 catenin (cadherin associated protein), beta 1 (Ctnnb1), mRNA [NM_007614] KLA 1.02 1.07 1.13 1.03 1.04 .93 .96
ATP 1.12 1.14 .75 .77 .73 .72 1.52
KLA/ATP 1.18 1.17 .77 .85 .60 .59 1.35
Ctnnbip1
KLA  ATP  ATP+KLA
 NM_023465 catenin beta interacting protein 1 (Ctnnbip1), mRNA [NM_023465] KLA .43 .39 .33 .34 .30 .40 .53
ATP .93 .85 1.11 .91 .75 .22 .37
KLA/ATP .39 .37 .41 .33 .37 .22 .14
Cul1
KLA  ATP  ATP+KLA
 NM_012042 cullin 1 (Cul1), mRNA [NM_012042] KLA 1.54 1.57 1.59 1.36 1.13 1.06 1.15
ATP 1.02 1.15 1.00 1.02 1.00 1.16 1.10
KLA/ATP 1.54 1.68 1.30 1.46 .98 1.02 1.12
Cxxc4
KLA  ATP  ATP+KLA
 NM_001004367 CXXC finger 4 (Cxxc4), mRNA [NM_001004367] KLA 1.00 1.02 1.04 .98 .95 1.00 1.02
ATP .95 1.01 1.03 1.05 1.04 1.02 1.07
KLA/ATP 1.01 .98 .99 1.10 1.11 1.14 1.01
Daam1
KLA  ATP  ATP+KLA
 AK053785 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130308H01 product:hypothetical protein, full insert sequence. [AK053785] KLA .96 .97 1.02 1.02 1.06 1.06 1.04
ATP 1.02 1.03 .98 .99 1.09 1.07 1.04
KLA/ATP 1.06 1.03 .98 1.02 .99 1.07 1.00
Daam1
KLA  ATP  ATP+KLA
 NM_026102 dishevelled associated activator of morphogenesis 1 (Daam1), transcript variant 1, mRNA [NM_026102] KLA 3.49 3.66 3.43 4.25 3.86 2.99 2.10
ATP 1.10 1.09 1.07 1.14 1.60 3.11 1.61
KLA/ATP 3.48 3.76 3.57 3.28 2.61 3.35 3.51
Daam2
KLA  ATP  ATP+KLA
 NM_001008231 dishevelled associated activator of morphogenesis 2 (Daam2), mRNA [NM_001008231] KLA 1.04 1.06 1.05 1.02 1.02 .97 1.02
ATP .96 1.05 1.01 .98 .95 .97 .94
KLA/ATP 1.01 .96 1.05 .98 1.04 1.00 1.01
Dkk1
KLA  ATP  ATP+KLA
 NM_010051 dickkopf homolog 1 (Xenopus laevis) (Dkk1), mRNA [NM_010051] KLA 1.01 .97 .99 1.01 .99 .97 1.05
ATP .99 1.01 .99 1.02 1.01 1.04 1.02
KLA/ATP 1.02 .99 .94 1.00 .99 1.02 .96
Dkk2
KLA  ATP  ATP+KLA
 NM_020265 dickkopf homolog 2 (Xenopus laevis) (Dkk2), mRNA [NM_020265] KLA .72 .81 .75 .78 .81 .76 .67
ATP 1.07 .98 .99 .95 .89 .80 .63
KLA/ATP .74 .75 .74 .91 .86 .78 .66
Dkk4
KLA  ATP  ATP+KLA
 NM_145592 dickkopf homolog 4 (Xenopus laevis) (Dkk4), mRNA [NM_145592] KLA .94 1.05 1.03 1.05 .98 .95 1.02
ATP 1.02 1.06 .95 .98 .98 1.02 .98
KLA/ATP 1.10 1.14 .99 .98 .97 .94 .94
Dvl1
KLA  ATP  ATP+KLA
 NM_010091 dishevelled, dsh homolog 1 (Drosophila) (Dvl1), mRNA [NM_010091] KLA .93 .91 .86 .74 .70 .80 1.05
ATP 1.01 1.01 .91 .91 .98 1.10 1.02
KLA/ATP 1.00 .93 .79 .82 .81 .85 1.06
Dvl2
KLA  ATP  ATP+KLA
 NM_007888 dishevelled 2, dsh homolog (Drosophila) (Dvl2), mRNA [NM_007888] KLA .49 .52 .48 .53 .52 .67 .75
ATP 1.08 1.08 .76 .93 1.47 .89 1.20
KLA/ATP .57 .47 .40 .61 1.37 .91 .92
Dvl3
KLA  ATP  ATP+KLA
 NM_007889 dishevelled 3, dsh homolog (Drosophila) (Dvl3), mRNA [NM_007889] KLA 1.08 1.09 1.05 1.18 1.11 1.10 1.11
ATP 1.00 1.01 1.05 1.05 .99 1.10 1.15
KLA/ATP 1.12 1.07 1.09 1.09 1.06 1.15 1.09
Ep300
KLA  ATP  ATP+KLA
 AK042627 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730011L11 product:P300 TRANSCRIPTION COACTIVATOR (FRAGMENT) homolog [Mus sp], full insert sequence. [AK042627] KLA 1.02 .95 .92 1.04 1.01 1.00 1.05
ATP 1.06 .89 .88 .89 1.00 .90 1.07
KLA/ATP 1.10 1.02 .87 .91 1.04 .97 .98
Ep300
KLA  ATP  ATP+KLA
 NM_177821 E1A binding protein p300 (Ep300), mRNA [NM_177821] KLA 1.61 1.26 1.57 1.38 1.78 1.41 1.40
ATP 1.34 1.60 1.11 1.08 1.16 1.05 1.15
KLA/ATP 1.86 1.94 1.18 1.56 1.71 1.42 2.05
Fbxw11
KLA  ATP  ATP+KLA
 AK010033 adult male tongue cDNA, RIKEN full-length enriched library, clone:2310065A07 product:unclassifiable, full insert sequence. [AK010033] KLA 1.30 1.21 1.27 1.21 1.47 1.01 1.13
ATP 1.19 2.03 1.28 .95 1.43 .99 1.04
KLA/ATP 1.43 1.83 1.40 1.10 1.12 1.05 1.05
Fbxw11
KLA  ATP  ATP+KLA
 NM_134015 F-box and WD-40 domain protein 11 (Fbxw11), mRNA [NM_134015] KLA 3.11 2.78 3.05 3.43 2.16 1.58 1.20
ATP 1.03 .94 1.72 1.19 1.38 1.66 1.01
KLA/ATP 2.76 2.70 4.18 2.07 1.91 2.02 1.71
Fosl1
KLA  ATP  ATP+KLA
 NM_010235 fos-like antigen 1 (Fosl1), mRNA [NM_010235] KLA .75 .72 .50 .55 .87 .97 1.29
ATP 1.00 .99 .72 1.57 7.76 9.10 2.11
KLA/ATP .83 .75 .53 .65 1.53 3.70 3.26
Frat1
KLA  ATP  ATP+KLA
 NM_008043 frequently rearranged in advanced T-cell lymphomas (Frat1), mRNA [NM_008043] KLA .65 .69 .63 .64 .60 .66 .59
ATP 1.05 1.03 .92 .94 .71 .73 .70
KLA/ATP .66 .68 .71 .69 .67 .63 .57
Frat2
KLA  ATP  ATP+KLA
 NM_177603 frequently rearranged in advanced T-cell lymphomas 2 (Frat2), mRNA [NM_177603] KLA .52 .66 .52 .71 .57 .53 .26
ATP 1.50 2.89 3.81 4.57 2.59 1.50 .33
KLA/ATP .56 .68 1.14 2.03 1.75 1.15 .35
Fzd1
KLA  ATP  ATP+KLA
 NM_021457 frizzled homolog 1 (Drosophila) (Fzd1), mRNA [NM_021457] KLA 15.53 16.47 14.36 11.40 6.80 2.73 2.49
ATP 1.01 1.02 1.39 2.05 6.43 10.47 1.41
KLA/ATP 12.71 14.30 14.99 14.06 9.72 9.90 8.10
Fzd10
KLA  ATP  ATP+KLA
 NM_175284 frizzled homolog 10 (Drosophila) (Fzd10), mRNA [NM_175284] KLA .99 .98 .99 1.03 1.03 1.02 .99
ATP .98 .98 .97 1.03 1.05 1.00 .96
KLA/ATP .96 .98 1.08 1.02 1.04 1.02 1.00
Fzd2
KLA  ATP  ATP+KLA
 NM_020510 frizzled homolog 2 (Drosophila) (Fzd2), mRNA [NM_020510] KLA .97 1.01 1.01 1.02 1.00 .96 .97
ATP 1.01 1.02 1.03 1.02 .97 1.03 .93
KLA/ATP 1.04 .98 .99 1.03 .99 1.03 .98
Fzd3
KLA  ATP  ATP+KLA
 NM_021458 frizzled homolog 3 (Drosophila) (Fzd3), mRNA [NM_021458] KLA 1.00 1.00 .99 1.04 1.02 1.06 1.07
ATP 1.00 1.00 .95 1.04 1.04 1.01 1.05
KLA/ATP .98 1.05 1.06 .99 1.02 1.00 1.03
Fzd4
KLA  ATP  ATP+KLA
 NM_008055 frizzled homolog 4 (Drosophila) (Fzd4), mRNA [NM_008055] KLA .96 .88 .91 .92 .82 .89 .84
ATP .97 .98 1.05 1.02 .93 .90 .96
KLA/ATP .82 .86 .97 .92 .88 .91 .92
Fzd5
KLA  ATP  ATP+KLA
 NM_022721 frizzled homolog 5 (Drosophila) (Fzd5), transcript variant 1, mRNA [NM_022721] KLA 1.63 1.69 1.56 1.23 .91 1.01 .92
ATP 1.03 1.32 4.46 9.23 7.72 2.14 1.11
KLA/ATP 1.63 1.92 4.20 8.67 8.29 3.07 1.12
Fzd6
KLA  ATP  ATP+KLA
 NM_008056 frizzled homolog 6 (Drosophila) (Fzd6), mRNA [NM_008056] KLA .97 1.01 .96 .90 .87 .94 .98
ATP .98 .97 .98 .94 .95 1.09 .96
KLA/ATP .97 1.02 .94 .92 .90 1.02 1.00
Fzd7
KLA  ATP  ATP+KLA
 NM_008057 frizzled homolog 7 (Drosophila) (Fzd7), mRNA [NM_008057] KLA 1.50 1.68 1.53 1.31 1.13 1.00 .94
ATP 1.04 1.12 1.60 3.45 2.56 1.72 1.02
KLA/ATP 1.89 1.92 1.96 4.61 3.75 3.38 1.88
Fzd8
KLA  ATP  ATP+KLA
 AK034561 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430006K02 product:inferred: transmembrane receptor {Mus musculus}; frizzled homolog 8 (Drosophila) homolog {GNF expression}, KLA 1.00 .98 1.05 .98 .96 1.03 .94
ATP 1.00 .92 1.06 1.05 1.02 1.01 .98
KLA/ATP .99 1.06 .99 .94 .95 .99 1.03
Fzd8
KLA  ATP  ATP+KLA
 NM_008058 frizzled homolog 8 (Drosophila) (Fzd8), mRNA [NM_008058] KLA 1.09 1.15 1.07 1.05 1.03 1.05 .98
ATP 1.05 1.08 2.01 3.38 2.89 1.20 1.03
KLA/ATP 1.04 1.17 1.65 2.57 2.62 1.40 1.04
Fzd9
KLA  ATP  ATP+KLA
 NM_010246 frizzled homolog 9 (Drosophila) (Fzd9), mRNA [NM_010246] KLA 1.03 1.10 1.12 .96 .98 1.00 .94
ATP 1.00 1.00 1.03 1.06 1.07 1.14 .98
KLA/ATP 1.10 1.07 1.03 .84 1.11 .96 .98
Gpc4
KLA  ATP  ATP+KLA
 AK020640 adult male urinary bladder cDNA, RIKEN full-length enriched library, clone:9530073D23 product:unclassifiable, full insert sequence. [AK020640] KLA 1.04 .96 .97 .99 1.00 .98 1.06
ATP .99 1.04 .96 1.02 1.00 1.02 .97
KLA/ATP 1.01 1.04 .99 .98 1.05 1.01 .98
Gpc4
KLA  ATP  ATP+KLA
 NM_008150 glypican 4 (Gpc4), mRNA [NM_008150] KLA 1.00 .99 .95 1.04 1.01 1.01 1.00
ATP 1.04 .95 .97 .97 .95 .98 .95
KLA/ATP .99 .98 .97 1.03 .94 .98 .97
Gsk3b
KLA  ATP  ATP+KLA
 NM_019827 glycogen synthase kinase 3 beta (Gsk3b), mRNA [NM_019827] KLA 1.06 1.03 1.11 1.01 1.26 1.28 1.26
ATP 1.18 1.27 1.15 2.07 2.37 2.32 1.67
KLA/ATP 1.15 1.21 .98 1.50 1.67 2.50 2.99
Jun
KLA  ATP  ATP+KLA
 NM_010591 Jun oncogene (Jun), mRNA [NM_010591] KLA 1.08 .96 1.09 1.09 .75 .88 .81
ATP 1.26 1.48 4.45 8.73 4.02 1.16 1.99
KLA/ATP 1.12 1.38 3.52 5.17 3.32 .49 1.42
Lef1
KLA  ATP  ATP+KLA
 NM_010703 lymphoid enhancer binding factor 1 (Lef1), mRNA [NM_010703] KLA 1.00 1.05 1.00 1.05 1.01 1.07 1.07
ATP .96 .98 1.03 1.09 .99 1.04 1.00
KLA/ATP 1.02 .98 .95 1.08 1.02 1.16 1.08
LOC10004
6483
KLA  ATP  ATP+KLA
 XM_001476285 ref|PREDICTED: Mus musculus similar to casein kinase II, alpha prime subunit (LOC100046483), mRNA [XM_001476285] KLA .97 .94 .94 .88 .84 .76 .88
ATP 1.06 1.04 .89 .82 .87 .70 .56
KLA/ATP 1.03 1.00 .88 .75 .73 .66 .43
Lrp5
KLA  ATP  ATP+KLA
 NM_008513 low density lipoprotein receptor-related protein 5 (Lrp5), mRNA [NM_008513] KLA .71 .74 .63 .69 .50 .50 .49
ATP 1.03 1.18 1.37 1.39 .86 .56 .38
KLA/ATP .76 .89 1.02 .88 .62 .52 .30
Lrp6
KLA  ATP  ATP+KLA
 AF074265 LDL receptor-related protein 6 (Lrp6) mRNA, complete cds [AF074265] KLA .83 .73 .80 .81 .71 .75 .79
ATP 1.04 1.06 1.16 .96 .89 1.14 .97
KLA/ATP .76 .84 .85 .80 .75 .92 .82
Map3k7
KLA  ATP  ATP+KLA
 NM_172688 mitogen-activated protein kinase kinase kinase 7 (Map3k7), mRNA [NM_172688] KLA 1.48 1.49 1.51 1.24 1.21 1.19 1.61
ATP 1.10 1.16 1.03 1.03 1.12 1.61 1.61
KLA/ATP 1.43 1.56 1.05 1.15 .85 1.48 1.76
Mapk10
KLA  ATP  ATP+KLA
 AK076990 adult male testis cDNA, RIKEN full-length enriched library, clone:4930597C01 product:mitogen activated protein kinase 10, full insert sequence. [AK076990] KLA 1.03 1.05 .98 1.04 .94 .95 1.02
ATP 1.00 .99 1.06 .97 1.01 .96 .99
KLA/ATP 1.07 1.01 .95 1.05 .82 .95 .87
Mapk10
KLA  ATP  ATP+KLA
 NM_009158 mitogen-activated protein kinase 10 (Mapk10), transcript variant 1, mRNA [NM_009158] KLA .95 1.00 .97 1.01 .99 1.01 .95
ATP 1.01 1.02 .98 1.01 1.04 1.01 .99
KLA/ATP 1.05 .99 1.01 .98 .92 .97 .98
Mapk8
KLA  ATP  ATP+KLA
 AK162915 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330031O19 product:mitogen activated protein kinase 8, full insert sequence [AK162915] KLA .94 .86 .80 .83 .77 .85 .83
ATP 1.08 1.12 .94 .80 .83 .71 .75
KLA/ATP .83 .81 .80 .74 .74 .75 .67
Mapk8
KLA  ATP  ATP+KLA
 AK163829 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130070A06 product:mitogen activated protein kinase 8, full insert sequence [AK163829] KLA .65 .61 .66 .70 .90 1.02 1.03
ATP .99 .94 1.68 1.44 1.75 1.84 1.10
KLA/ATP .63 .67 1.11 1.00 2.01 1.68 1.15
Mapk8
KLA  ATP  ATP+KLA
 NM_016700 mitogen-activated protein kinase 8 (Mapk8), mRNA [NM_016700] KLA .96 1.00 .94 .96 .94 .99 1.04
ATP 1.01 1.05 1.01 .99 1.03 .98 1.02
KLA/ATP .96 .97 .96 .97 .93 .94 .96
Mapk9
KLA  ATP  ATP+KLA
 NM_016961 mitogen-activated protein kinase 9 (Mapk9), transcript variant 2, mRNA [NM_016961] KLA 1.28 1.37 1.59 1.60 1.61 1.43 1.38
ATP 1.03 .99 .74 .71 .79 1.20 1.01
KLA/ATP 1.53 1.30 1.07 .99 .83 1.10 1.40
Mapk9
KLA  ATP  ATP+KLA
 NM_207692 mitogen-activated protein kinase 9 (Mapk9), transcript variant 1, mRNA [NM_207692] KLA 1.39 1.53 1.69 1.69 1.55 1.44 1.51
ATP .95 .92 .75 .85 .70 1.46 1.17
KLA/ATP 1.37 1.35 .99 1.18 .91 1.22 1.62
Mm.13153
0
KLA  ATP  ATP+KLA
 161086915 Unknown KLA 1.00 1.07 1.14 1.08 .97 1.00 .93
ATP 1.04 .99 1.00 .95 .99 1.02 .90
KLA/ATP 1.08 1.18 1.14 1.16 1.04 1.06 1.08
Mm.15031
4
KLA  ATP  ATP+KLA
 158508450 Unknown KLA 1.32 1.36 1.33 1.51 1.56 1.59 1.70
ATP .93 1.00 1.37 1.02 1.16 1.24 .95
KLA/ATP 1.22 1.26 1.27 1.14 1.28 1.27 1.31
Mm.21516
1
KLA  ATP  ATP+KLA
 141801906 Unknown KLA 1.08 1.09 1.10 1.08 1.09 1.05 1.12
ATP .95 .94 1.05 1.16 1.05 1.08 1.14
KLA/ATP 1.07 1.15 1.16 1.16 1.10 1.14 1.14
Mm.23692
KLA  ATP  ATP+KLA
 164565453 Unknown KLA .83 .77 .72 .65 .61 .75 .80
ATP .77 .94 1.03 .63 .61 .74 .59
KLA/ATP .58 .78 .77 .52 .51 .56 .30
Mm.24600
3
KLA  ATP  ATP+KLA
 161086914 Unknown KLA 10.04 10.23 11.14 8.37 5.02 2.48 2.15
ATP .96 1.08 1.11 1.79 4.88 8.01 1.29
KLA/ATP 9.96 11.13 9.87 10.92 7.51 7.35 6.26
Mm.27304
9
KLA  ATP  ATP+KLA
 119672895 Unknown KLA .23 .22 .22 .22 .30 .51 .16
ATP 1.08 1.05 .88 .78 .47 .09 .20
KLA/ATP .28 .22 .21 .24 .26 .22 .12
Mm.28819
4
KLA  ATP  ATP+KLA
 94388003 Unknown KLA .97 .98 .97 1.02 1.04 .97 .87
ATP .97 1.00 .99 1.00 1.02 1.04 1.03
KLA/ATP 1.04 .91 1.05 1.05 .93 .96 1.06
Mm.33138
9
KLA  ATP  ATP+KLA
 158508469 Unknown KLA .80 .79 .81 .82 .72 .64 .50
ATP .95 .85 .56 .48 .30 .33 .46
KLA/ATP .71 .64 .50 .41 .33 .32 .42
Mm.38910
5
KLA  ATP  ATP+KLA
 94363244 Unknown KLA 1.00 1.05 1.11 1.10 1.05 1.18 1.11
ATP 1.00 1.04 1.07 1.01 1.06 1.06 1.03
KLA/ATP 1.05 .96 1.11 1.18 1.07 1.09 .97
Mm.42395
9
KLA  ATP  ATP+KLA
 159032048 Unknown KLA 1.07 1.11 1.03 1.08 .97 1.08 1.09
ATP .98 1.12 1.05 1.08 1.07 1.12 1.09
KLA/ATP 1.08 1.05 1.18 1.05 1.17 1.11 1.07
Mm.45938
1
KLA  ATP  ATP+KLA
 52345427 Unknown KLA .99 .97 .97 1.01 .98 1.01 1.04
ATP 1.05 .97 1.03 1.10 .96 .97 .99
KLA/ATP .99 .99 1.04 .98 1.01 .94 1.01
Mm.4769
KLA  ATP  ATP+KLA
 31542830 Unknown KLA .93 .99 .86 .85 .75 .83 .80
ATP 1.01 1.00 .91 .83 .96 1.15 .84
KLA/ATP .95 .95 .92 .81 .85 1.12 .87
Mm.56964
KLA  ATP  ATP+KLA
 144227223 Unknown KLA .96 .99 1.00 .99 .97 1.01 1.05
ATP .99 .94 1.00 .94 .97 .99 .91
KLA/ATP 1.05 .97 1.02 .97 .91 1.00 1.02
Mm.71710
KLA  ATP  ATP+KLA
 158966712 Unknown KLA 1.23 1.26 1.52 1.32 1.46 1.45 1.38
ATP .98 1.07 1.18 1.51 1.49 1.15 1.18
KLA/ATP 1.27 1.45 1.29 1.61 1.65 1.41 1.54
Mm.998
KLA  ATP  ATP+KLA
 118130584 Unknown KLA 1.14 1.17 1.21 1.06 1.22 1.16 1.13
ATP 1.02 1.07 1.06 .97 .92 1.01 .98
KLA/ATP 1.05 1.17 1.22 1.24 1.13 1.07 1.12
Mmp7
KLA  ATP  ATP+KLA
 NM_010810 matrix metallopeptidase 7 (Mmp7), mRNA [NM_010810] KLA 1.08 1.13 1.14 1.26 1.20 1.22 1.24
ATP 1.00 1.00 1.00 1.12 1.14 1.17 1.14
KLA/ATP 1.25 1.14 1.23 1.15 1.09 1.32 1.22
Myc
KLA  ATP  ATP+KLA
 NM_010849 myelocytomatosis oncogene (Myc), mRNA [NM_010849] KLA .38 .31 .45 .45 .49 .35 .33
ATP 1.05 1.09 1.72 4.41 1.28 .45 .76
KLA/ATP .37 .30 .44 1.23 .34 .17 .19
Nfat5
KLA  ATP  ATP+KLA
 AK172011 activated spleen cDNA, RIKEN full-length enriched library, clone:F830029B05 product:nuclear factor of activated T-cells 5, full insert sequence. [AK172011] KLA .94 .90 .93 .93 1.28 1.27 1.16
ATP .95 .76 1.13 1.27 1.93 2.21 1.18
KLA/ATP .85 .84 1.10 .92 1.53 1.63 1.66
Nfat5
KLA  ATP  ATP+KLA
 NM_018823 nuclear factor of activated T-cells 5 (Nfat5), transcript variant b, mRNA [NM_018823] KLA .95 1.01 .99 1.03 1.08 1.13 1.19
ATP 1.05 1.22 1.67 1.98 1.74 1.38 1.17
KLA/ATP 1.03 1.07 1.34 1.38 1.30 1.19 1.40
Nfat5
KLA  ATP  ATP+KLA
 NM_133957 nuclear factor of activated T-cells 5 (Nfat5), transcript variant a, mRNA [NM_133957] KLA 1.07 1.07 1.00 .96 1.42 1.36 1.51
ATP 1.15 1.19 1.81 4.36 6.34 3.49 1.12
KLA/ATP 1.27 1.08 1.87 2.72 3.58 3.05 2.07
Nfatc1
KLA  ATP  ATP+KLA
 NM_016791 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (Nfatc1), transcript variant 1, mRNA [NM_016791] KLA .71 .66 .68 .62 .63 .67 .81
ATP 1.12 1.29 1.15 1.21 .83 .63 1.25
KLA/ATP .78 .79 .65 .74 .59 .45 .92
Nfatc1
KLA  ATP  ATP+KLA
 NM_198429 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (Nfatc1), transcript variant 2, mRNA [NM_198429] KLA .49 .41 .50 .43 .50 .78 .69
ATP 1.05 .81 .84 .54 .60 .38 .69
KLA/ATP .46 .37 .45 .32 .62 .39 .61
Nfatc2
KLA  ATP  ATP+KLA
 AK081853 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130082H17 product:nuclear factor of activated T-cells, cytoplasmic 2, full insert sequence. [AK081853] KLA .56 .52 .59 .61 .78 .78 .66
ATP 1.19 1.27 .67 .65 .62 .53 .79
KLA/ATP .52 .49 .71 .57 .65 .52 .53
Nfatc2
KLA  ATP  ATP+KLA
 NM_001037177 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 (Nfatc2), transcript variant 2, mRNA [NM_001037177] KLA .84 .79 .74 .82 .89 .98 .80
ATP 1.06 1.13 1.01 .87 .86 .83 1.10
KLA/ATP .76 .72 .89 .84 .84 .81 .84
Nfatc2
KLA  ATP  ATP+KLA
 NM_010899 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 (Nfatc2), transcript variant 1, mRNA [NM_010899] KLA .90 .91 .86 .91 .86 1.07 1.00
ATP 1.08 1.11 1.45 1.04 .88 .85 1.18
KLA/ATP .85 .89 .92 .89 .93 .84 1.13
Nfatc3
KLA  ATP  ATP+KLA
 AK084848 13 days embryo lung cDNA, RIKEN full-length enriched library, clone:D430001G08 product:nuclear factor of activated T-cells, cytoplasmic 3, full insert sequence. [AK084848] KLA 1.08 .96 .98 1.00 .98 1.03 .98
ATP 1.00 1.03 .93 .92 .92 1.11 .98
KLA/ATP 1.01 .87 1.10 .97 .96 .96 .99
Nfatc3
KLA  ATP  ATP+KLA
 NM_010901 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 (Nfatc3), mRNA [NM_010901] KLA .77 .68 .67 .77 .85 .90 1.04
ATP 1.01 .95 .89 .70 .70 .92 .98
KLA/ATP .77 .66 .64 .59 .82 .90 .90
Nfatc4
KLA  ATP  ATP+KLA
 AK014164 13 days embryo head cDNA, RIKEN full-length enriched library, clone:3110041H08 product:nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4, full insert sequence. [AK014164] KLA .90 .92 .91 1.00 .99 .98 .95
ATP .90 1.03 .96 .98 .95 .97 1.00
KLA/ATP .95 .87 1.00 .98 .96 .96 .92
Nfatc4
KLA  ATP  ATP+KLA
 NM_023699 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 (Nfatc4), mRNA [NM_023699] KLA 1.28 1.38 1.44 1.58 1.40 1.41 1.46
ATP 1.03 1.06 1.23 1.24 1.32 1.40 1.41
KLA/ATP 1.30 1.38 1.47 1.28 1.38 1.40 1.63
Nkd1
KLA  ATP  ATP+KLA
 AK076164 14, 17 days embryo head cDNA, RIKEN full-length enriched library, clone:3230401D10 product:naked cuticle 1 homolog (Drosophila), full insert sequence [AK076164] KLA .99 1.02 .98 1.09 .92 .98 .97
ATP .97 1.00 1.01 .89 .95 1.00 1.01
KLA/ATP 1.03 1.00 1.01 .97 .90 1.01 .94
Nkd1
KLA  ATP  ATP+KLA
 NM_027280 naked cuticle 1 homolog (Drosophila) (Nkd1), mRNA [NM_027280] KLA 1.01 1.01 .96 1.08 1.02 1.03 .94
ATP .95 1.09 1.00 .99 1.00 1.02 1.00
KLA/ATP .96 .95 .97 1.00 .96 .99 1.08
Nkd2
KLA  ATP  ATP+KLA
 NM_028186 naked cuticle 2 homolog (Drosophila) (Nkd2), mRNA [NM_028186] KLA .96 1.00 1.00 1.02 .99 .99 .95
ATP 1.05 1.02 1.01 1.03 .97 1.04 .97
KLA/ATP 1.00 1.06 .97 .99 .97 .96 .87
Nlk
KLA  ATP  ATP+KLA
 NM_008702 nemo like kinase (Nlk), mRNA [NM_008702] KLA .71 .70 .64 .71 .78 .95 .94
ATP .91 .89 .95 .70 .45 .64 1.05
KLA/ATP .61 .66 .84 .54 .53 .58 .79
Plcb1
KLA  ATP  ATP+KLA
 AK129166 mRNA for mKIAA0581 protein [AK129166] KLA 1.02 .98 .91 .91 .92 .95 .89
ATP 1.03 1.02 1.02 1.01 .90 1.02 1.04
KLA/ATP .98 .97 .91 .93 .92 1.01 1.16
Plcb1
KLA  ATP  ATP+KLA
 NM_019677 phospholipase C, beta 1 (Plcb1), mRNA [NM_019677] KLA .99 .94 .95 .97 .93 .92 .91
ATP 1.00 .96 .99 .95 .99 1.03 .98
KLA/ATP .93 .96 .94 .93 .87 1.00 1.06
Plcb2
KLA  ATP  ATP+KLA
 NM_177568 phospholipase C, beta 2 (Plcb2), mRNA [NM_177568] KLA .70 .68 .64 .67 .65 .76 .88
ATP .95 .94 1.04 .94 .72 .57 1.19
KLA/ATP .69 .68 .72 .63 .65 .55 .70
Plcb3
KLA  ATP  ATP+KLA
 NM_008874 phospholipase C, beta 3 (Plcb3), mRNA [NM_008874] KLA 1.72 1.78 1.82 1.65 1.67 1.44 1.21
ATP .97 1.04 .81 .87 .78 .88 .94
KLA/ATP 1.69 1.89 1.44 1.66 1.12 .73 .93
Plcb4
KLA  ATP  ATP+KLA
 AK082509 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230058B11 product:unclassifiable, full insert sequence. [AK082509] KLA 1.06 1.03 .97 .98 1.02 1.01 .99
ATP .99 1.07 1.09 .95 .97 .97 1.02
KLA/ATP .98 1.00 1.03 .96 1.02 .91 .98
Plcb4
KLA  ATP  ATP+KLA
 NM_013829 phospholipase C, beta 4 (Plcb4), mRNA [NM_013829] KLA .88 .94 .81 .82 .81 .86 1.01
ATP 1.00 1.01 .92 .93 .88 .85 .89
KLA/ATP .97 .94 .78 .80 .78 .86 .97
Porcn
KLA  ATP  ATP+KLA
 NM_023638 porcupine homolog (Drosophila) (Porcn), transcript variant Mporc-d, mRNA [NM_023638] KLA .86 .83 .83 .81 .77 .77 1.07
ATP .99 1.00 .91 .96 .76 .61 .94
KLA/ATP .89 .86 .78 .80 .71 .69 .66
Ppard
KLA  ATP  ATP+KLA
 NM_011145 peroxisome proliferator activator receptor delta (Ppard), mRNA [NM_011145] KLA 1.04 .97 1.09 1.04 1.14 .99 1.11
ATP 1.03 .97 .94 1.01 1.36 1.49 1.11
KLA/ATP 1.00 1.00 .94 1.07 1.20 1.29 1.17
Ppp3ca
KLA  ATP  ATP+KLA
 NM_008913 protein phosphatase 3, catalytic subunit, alpha isoform (Ppp3ca), mRNA [NM_008913] KLA .76 .85 .81 .85 .73 .70 .52
ATP .96 .78 .55 .46 .31 .33 .48
KLA/ATP .74 .64 .52 .42 .37 .36 .45
Ppp3cb
KLA  ATP  ATP+KLA
 AK135203 12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720421K10 product:protein phosphatase 3, catalytic subunit, beta isoform, full insert sequence. [AK135203] KLA 1.74 1.57 1.91 1.59 1.47 1.26 1.40
ATP 1.17 1.03 1.30 1.00 .81 .62 1.37
KLA/ATP 1.68 1.70 1.91 1.37 1.09 .47 1.13
Ppp3cb
KLA  ATP  ATP+KLA
 AK171904 activated spleen cDNA, RIKEN full-length enriched library, clone:F830018L06 product:Protein phosphatase 3 catalytic subunit beta3 (EC 3.1.3.16) (Serine [AK171904] KLA 1.29 1.29 1.21 1.15 1.22 1.13 1.28
ATP .90 .86 .80 .98 .94 .73 .92
KLA/ATP 1.06 1.03 .77 1.04 .92 .68 .90
Ppp3cb
KLA  ATP  ATP+KLA
 NM_008914 protein phosphatase 3, catalytic subunit, beta isoform (Ppp3cb), mRNA [NM_008914] KLA 1.21 1.29 1.38 1.24 1.29 1.08 1.23
ATP 1.15 1.31 1.09 1.29 .86 .60 .64
KLA/ATP 1.33 1.40 1.04 1.28 .79 .58 .73
Ppp3cc
KLA  ATP  ATP+KLA
 AK037563 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130026K22 product:unclassifiable, full insert sequence [AK037563] KLA 1.27 1.18 1.21 1.15 1.01 .92 1.36
ATP .96 1.09 1.10 1.03 .85 1.06 1.47
KLA/ATP 1.17 1.24 1.07 1.13 .91 .88 1.36
Ppp3cc
KLA  ATP  ATP+KLA
 NM_008915 protein phosphatase 3, catalytic subunit, gamma isoform (Ppp3cc), mRNA [NM_008915] KLA 1.64 1.81 1.79 1.35 .90 .70 1.31
ATP .90 .90 1.13 .93 .86 1.40 1.60
KLA/ATP 1.45 1.62 1.74 1.47 1.04 1.01 1.31
Ppp3r1
KLA  ATP  ATP+KLA
 NM_024459 protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I) (Ppp3r1), mRNA [NM_024459] KLA 1.02 1.17 .93 1.27 1.15 1.30 1.30
ATP .97 .95 .77 .91 .99 1.18 1.10
KLA/ATP 1.12 1.04 .88 1.00 1.10 1.10 1.07
Ppp3r2
KLA  ATP  ATP+KLA
 NM_001004025 protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type II) (Ppp3r2), mRNA [NM_001004025] KLA 1.03 1.05 1.06 1.08 1.12 1.05 1.04
ATP 1.00 1.02 1.04 1.04 .99 .99 1.01
KLA/ATP 1.04 1.12 1.03 1.09 1.00 .99 1.00
Prickle1
KLA  ATP  ATP+KLA
 NM_001033217 prickle like 1 (Drosophila) (Prickle1), mRNA [NM_001033217] KLA 1.12 1.24 1.16 1.11 1.27 1.15 1.19
ATP .95 1.14 1.14 .92 .98 1.02 .91
KLA/ATP 1.07 1.13 1.09 .98 1.07 .98 1.14
Prickle2
KLA  ATP  ATP+KLA
 AK147628 cDNA, RIKEN full-length enriched library, clone:M5C1096L03 product:Similar to prickle-like 1 (Drosophila) (Fragment) homolog [Mus musculus], full insert sequence [AK147628] KLA 1.05 1.00 .96 1.00 1.06 .97 1.04
ATP .98 1.00 1.02 1.07 1.01 .99 1.03
KLA/ATP 1.01 .96 .98 1.04 1.03 1.05 1.01
Prickle2
KLA  ATP  ATP+KLA
 NM_001081146 prickle-like 2 (Drosophila) (Prickle2), mRNA [NM_001081146] KLA 1.06 .97 1.08 1.10 1.03 1.07 1.05
ATP 1.03 1.02 1.20 .99 1.01 1.12 1.09
KLA/ATP .99 .96 1.09 1.06 1.05 .98 1.08
Prkaca
KLA  ATP  ATP+KLA
 NM_008854 protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] KLA .71 .74 .72 .70 .72 .84 .85
ATP 1.05 .98 .89 .92 .76 .60 1.02
KLA/ATP .79 .74 .55 .65 .60 .65 .93
Prkacb
KLA  ATP  ATP+KLA
 NM_011100 protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] KLA .69 .70 .66 .58 .51 .55 .59
ATP 1.02 1.19 .97 1.01 .69 .38 .56
KLA/ATP .72 .73 .57 .62 .47 .41 .45
Prkca
KLA  ATP  ATP+KLA
 NM_011101 protein kinase C, alpha (Prkca), mRNA [NM_011101] KLA 1.00 .96 .94 .95 .95 .89 .96
ATP 1.00 1.03 .91 .94 .82 .87 1.13
KLA/ATP 1.02 .95 .91 .86 .78 .84 .94
Prkcb1
KLA  ATP  ATP+KLA
 NM_008855 protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] KLA .92 .95 .93 .78 .77 1.08 1.83
ATP 1.03 1.12 1.09 1.23 .90 2.08 .96
KLA/ATP .98 .99 .82 .89 .62 1.01 1.08
Prkcc
KLA  ATP  ATP+KLA
 NM_011102 protein kinase C, gamma (Prkcc), mRNA [NM_011102] KLA 1.02 1.04 1.11 1.04 .96 1.02 1.05
ATP .98 .98 1.05 1.03 1.08 .96 .95
KLA/ATP 1.21 1.16 1.09 1.07 1.04 .98 .93
Prkx
KLA  ATP  ATP+KLA
 NM_016979 protein kinase, X-linked (Prkx), mRNA [NM_016979] KLA 3.61 3.79 4.67 4.66 4.85 4.19 1.43
ATP .98 .90 .63 .61 1.12 1.90 1.29
KLA/ATP 3.56 3.36 2.62 2.06 2.26 2.87 2.31
Psen1
KLA  ATP  ATP+KLA
 NM_008943 presenilin 1 (Psen1), mRNA [NM_008943] KLA 1.22 1.31 1.54 1.90 2.50 2.67 2.01
ATP 1.04 1.10 .89 1.00 1.21 2.18 1.73
KLA/ATP 1.33 1.37 1.22 1.52 1.69 2.61 2.95
Rac1
KLA  ATP  ATP+KLA
 NM_009007 RAS-related C3 botulinum substrate 1 (Rac1), mRNA [NM_009007] KLA 1.02 1.01 1.02 .99 1.03 1.15 1.08
ATP .99 1.15 1.01 1.27 1.06 1.20 1.06
KLA/ATP 1.00 1.04 .88 1.16 .91 1.21 1.38
Rac2
KLA  ATP  ATP+KLA
 NM_009008 RAS-related C3 botulinum substrate 2 (Rac2), mRNA [NM_009008] KLA 1.55 1.68 1.86 2.15 3.36 3.59 3.74
ATP 1.13 1.16 .74 .99 .84 .91 1.66
KLA/ATP 1.59 1.71 1.19 1.56 1.21 1.60 3.48
Rac3
KLA  ATP  ATP+KLA
 NM_133223 RAS-related C3 botulinum substrate 3 (Rac3), mRNA [NM_133223] KLA 2.03 2.20 2.64 2.18 2.95 2.29 1.41
ATP 1.02 1.12 .94 1.42 1.16 .84 .87
KLA/ATP 2.30 2.32 1.57 2.55 1.75 1.47 1.61
Rbx1
KLA  ATP  ATP+KLA
 NM_019712 ring-box 1 (Rbx1), mRNA [NM_019712] KLA 1.04 1.01 .98 1.09 1.06 1.14 1.09
ATP .92 .89 1.13 1.16 1.68 1.07 .83
KLA/ATP .99 .99 1.25 1.31 2.63 2.06 .67
Rhoa
KLA  ATP  ATP+KLA
 NM_016802 ras homolog gene family, member A (Rhoa), mRNA [NM_016802] KLA .93 1.00 1.07 .97 1.08 1.06 1.02
ATP .93 .88 .49 .61 .63 .78 1.05
KLA/ATP .94 .92 .59 .63 .61 .78 1.12
Rock1
KLA  ATP  ATP+KLA
 NM_009071 Rho-associated coiled-coil containing protein kinase 1 (Rock1), mRNA [NM_009071] KLA 2.40 2.48 2.37 3.07 1.94 1.42 1.21
ATP .95 .92 .87 .70 1.13 1.74 .98
KLA/ATP 2.27 2.35 2.56 1.60 1.65 1.56 1.23
Rock2
KLA  ATP  ATP+KLA
 NM_009072 Rho-associated coiled-coil containing protein kinase 2 (Rock2), mRNA [NM_009072] KLA .99 .92 .83 .87 .73 .74 1.04
ATP 1.07 1.31 1.16 1.02 1.02 1.03 .88
KLA/ATP 1.00 1.07 .93 .85 .69 .63 .81
Ruvbl1
KLA  ATP  ATP+KLA
 NM_019685 RuvB-like protein 1 (Ruvbl1), mRNA [NM_019685] KLA 1.06 1.08 1.08 .99 .92 .83 .84
ATP 1.05 1.08 1.13 1.25 1.05 .83 .77
KLA/ATP 1.10 1.20 1.22 1.24 .91 .63 .49
Senp2
KLA  ATP  ATP+KLA
 AK009212 adult male tongue cDNA, RIKEN full-length enriched library, clone:2310007L05 product:unclassifiable, full insert sequence. [AK009212] KLA .67 .72 .63 .58 .57 .59 .70
ATP .96 .90 .98 .88 .96 .90 .61
KLA/ATP .64 .60 .68 .63 .77 .73 .40
Senp2
KLA  ATP  ATP+KLA
 NM_029457 SUMO/sentrin specific peptidase 2 (Senp2), mRNA [NM_029457] KLA .83 .81 .82 .70 .69 .75 1.19
ATP .98 1.01 .90 1.00 1.09 1.45 1.74
KLA/ATP .85 .85 .68 .75 .67 1.08 1.64
Sfrp1
KLA  ATP  ATP+KLA
 NM_013834 secreted frizzled-related protein 1 (Sfrp1), mRNA [NM_013834] KLA 1.06 1.06 1.01 1.00 1.02 .98 1.04
ATP 1.00 .97 .97 1.00 .99 .97 1.01
KLA/ATP 1.03 .99 .98 1.01 1.01 1.01 1.04
Sfrp2
KLA  ATP  ATP+KLA
 NM_009144 secreted frizzled-related protein 2 (Sfrp2), mRNA [NM_009144] KLA 1.00 1.05 1.00 1.01 1.08 1.00 .96
ATP 1.01 1.07 1.04 .95 .97 1.03 .92
KLA/ATP .99 1.02 1.05 1.09 1.04 .88 1.02
Sfrp4
KLA  ATP  ATP+KLA
 NM_016687 secreted frizzled-related protein 4 (Sfrp4), mRNA [NM_016687] KLA 1.03 1.02 1.16 1.17 1.18 1.07 .91
ATP 1.02 1.05 .97 1.03 1.01 .99 .95
KLA/ATP 1.04 1.00 1.27 1.14 1.02 1.32 1.07
Sfrp5
KLA  ATP  ATP+KLA
 NM_018780 secreted frizzled-related sequence protein 5 (Sfrp5), mRNA [NM_018780] KLA .99 1.05 .92 1.05 1.11 1.03 1.08
ATP 1.02 1.01 .96 1.03 .96 .98 1.03
KLA/ATP 1.04 .97 .93 1.00 1.01 .98 .97
Siah1a
KLA  ATP  ATP+KLA
 NM_009172 seven in absentia 1A (Siah1a), mRNA [NM_009172] KLA 1.09 1.05 1.03 1.00 1.21 1.17 1.29
ATP .95 .99 .82 .77 1.02 .98 .98
KLA/ATP 1.06 1.04 .82 .78 .76 .85 1.06
Siah1b
KLA  ATP  ATP+KLA
 NM_009173 seven in absentia 1B (Siah1b), mRNA [NM_009173] KLA 1.20 1.10 1.09 1.08 1.00 .91 .84
ATP .97 .90 .79 .75 1.46 1.24 .84
KLA/ATP 1.06 1.08 .85 .66 1.21 1.40 1.08
Skp1a
KLA  ATP  ATP+KLA
 NM_011543 S-phase kinase-associated protein 1A (Skp1a), mRNA [NM_011543] KLA 1.05 1.00 .92 .92 .88 .89 1.02
ATP .90 .98 1.21 1.43 1.32 1.46 1.09
KLA/ATP .93 1.01 1.11 1.31 1.21 1.27 1.21
Smad3
KLA  ATP  ATP+KLA
 NM_016769 MAD homolog 3 (Drosophila) (Smad3), mRNA [NM_016769] KLA .64 .60 .57 .64 .70 1.25 1.52
ATP 1.02 1.02 .84 1.21 2.42 .90 1.19
KLA/ATP .64 .60 .65 .66 1.29 1.26 2.26
Smad4
KLA  ATP  ATP+KLA
 NM_008540 MAD homolog 4 (Drosophila) (Smad4), mRNA [NM_008540] KLA 1.11 1.11 1.13 1.09 1.02 .98 1.08
ATP 1.00 1.04 .92 .76 1.67 1.44 .92
KLA/ATP 1.09 1.01 .87 .89 1.64 1.43 .99
Sost
KLA  ATP  ATP+KLA
 NM_024449 sclerostin (Sost), mRNA [NM_024449] KLA 1.04 1.08 1.04 1.06 1.03 1.13 1.09
ATP .99 .96 1.03 1.06 1.00 1.02 1.05
KLA/ATP 1.03 1.07 1.03 1.04 1.06 1.02 .99
Sox17
KLA  ATP  ATP+KLA
 AK051370 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130041E14 product:inferred: SRY-box containing gene 17 / unnamed protein product {Homo sapiens}, full insert sequence. [AK051370] KLA 1.01 1.01 .96 1.01 1.04 1.03 1.01
ATP .94 .93 .94 .98 .96 1.01 1.01
KLA/ATP .95 1.00 1.10 1.07 1.04 .98 .92
Sox17
KLA  ATP  ATP+KLA
 NM_011441 SRY-box containing gene 17 (Sox17), mRNA [NM_011441] KLA .97 .97 1.03 1.01 1.00 1.05 1.02
ATP 1.05 1.00 .95 1.05 1.04 .93 1.01
KLA/ATP 1.00 .99 .98 1.00 1.00 1.02 .98
Tbl1x
KLA  ATP  ATP+KLA
 NM_020601 transducin (beta)-like 1 X-linked (Tbl1x), mRNA [NM_020601] KLA 2.19 2.44 2.35 2.23 1.95 1.53 1.21
ATP 1.04 1.15 .91 1.15 .74 .54 .88
KLA/ATP 2.49 2.45 1.85 2.43 1.20 .71 .98
Tbl1xr1
KLA  ATP  ATP+KLA
 NM_030732 transducin (beta)-like 1X-linked receptor 1 (Tbl1xr1), mRNA [NM_030732] KLA .83 .77 .80 .86 1.00 1.30 1.57
ATP 1.09 1.10 1.15 1.33 1.08 1.41 4.88
KLA/ATP .90 .84 .75 .81 .83 1.21 5.26
Tcf3
KLA  ATP  ATP+KLA
 NM_001079822 transcription factor 3 (Tcf3), transcript variant 1, mRNA [NM_001079822] KLA 1.03 .98 1.01 .98 .98 1.03 1.01
ATP 1.00 1.02 1.00 1.06 1.10 1.07 .99
KLA/ATP 1.07 .99 .97 1.05 1.05 1.11 .96
Tcf7
KLA  ATP  ATP+KLA
 NM_009331 transcription factor 7, T-cell specific (Tcf7), mRNA [NM_009331] KLA 1.00 1.01 1.03 1.00 .98 1.01 1.07
ATP .99 .98 1.02 1.03 1.03 1.00 1.01
KLA/ATP 1.00 1.03 1.04 1.02 1.04 1.02 1.00
Tcf7l2
KLA  ATP  ATP+KLA
 NM_009333 transcription factor 7-like 2, T-cell specific, HMG-box (Tcf7l2), mRNA [NM_009333] KLA 1.01 1.12 1.11 1.31 1.06 1.34 1.29
ATP 1.04 1.05 .94 1.06 .90 .81 .96
KLA/ATP 1.08 1.11 1.05 1.18 1.04 1.02 1.42
Trp53
KLA  ATP  ATP+KLA
 NM_011640 transformation related protein 53 (Trp53), mRNA [NM_011640] KLA 1.25 1.37 1.11 .86 .72 .71 .95
ATP 1.15 1.32 .90 1.85 1.26 .68 .70
KLA/ATP 1.66 1.49 .80 1.76 .81 .65 .74
Vangl1
KLA  ATP  ATP+KLA
 BC024687 vang-like 1 (van gogh, Drosophila), mRNA (cDNA clone IMAGE:3669388), partial cds [BC024687] KLA .48 .47 .44 .55 .46 .48 .55
ATP .95 1.02 1.04 .82 .54 .56 .70
KLA/ATP .44 .48 .54 .53 .48 .46 .39
Vangl1
KLA  ATP  ATP+KLA
 NM_177545 vang-like 1 (van gogh, Drosophila) (Vangl1), mRNA [NM_177545] KLA .81 .81 .74 .85 .75 .71 .81
ATP 1.10 1.02 1.03 .88 .79 .98 1.06
KLA/ATP .83 .86 .82 .72 .67 .82 .84
Vangl2
KLA  ATP  ATP+KLA
 BC075636 loop tail associated protein, mRNA (cDNA clone IMAGE:30545600), partial cds [BC075636] KLA .82 .79 .75 .83 .79 .83 .91
ATP 1.07 1.03 .89 .80 .72 .83 .88
KLA/ATP .83 .81 .76 .75 .81 .78 .86
Vangl2
KLA  ATP  ATP+KLA
 NM_033509 vang-like 2 (van gogh, Drosophila) (Vangl2), mRNA [NM_033509] KLA .80 .93 .81 .79 .78 .87 .92
ATP 1.00 .98 1.15 .86 .75 .83 1.09
KLA/ATP .91 .85 .83 .85 .70 .84 1.00
Wif1
KLA  ATP  ATP+KLA
 NM_011915 Wnt inhibitory factor 1 (Wif1), mRNA [NM_011915] KLA .96 1.01 1.02 .97 .98 .97 1.04
ATP .99 .98 .97 .99 1.01 1.02 .91
KLA/ATP .99 1.03 1.00 .99 .95 .99 .94
Wnt1
KLA  ATP  ATP+KLA
 NM_021279 wingless-related MMTV integration site 1 (Wnt1), mRNA [NM_021279] KLA 1.01 1.01 1.05 1.03 1.04 1.04 1.01
ATP .99 .99 1.01 .97 .96 1.01 1.00
KLA/ATP 1.01 1.04 1.06 1.02 1.00 .98 .98
Wnt10a
KLA  ATP  ATP+KLA
 NM_009518 wingless related MMTV integration site 10a (Wnt10a), mRNA [NM_009518] KLA 1.73 1.66 1.33 1.17 1.10 1.02 1.03
ATP 1.03 1.04 .93 1.02 1.04 1.07 1.06
KLA/ATP 1.83 1.67 1.53 1.21 1.10 1.12 1.09
Wnt10b
KLA  ATP  ATP+KLA
 NM_011718 wingless related MMTV integration site 10b (Wnt10b), mRNA [NM_011718] KLA 1.10 .98 1.13 1.01 .96 1.00 .96
ATP 1.02 1.02 .99 1.01 .96 1.02 1.01
KLA/ATP 1.01 1.18 .97 .97 1.03 1.04 .98
Wnt11
KLA  ATP  ATP+KLA
 NM_009519 wingless-related MMTV integration site 11 (Wnt11), mRNA [NM_009519] KLA .97 1.00 .97 1.03 1.16 1.08 1.11
ATP 1.03 1.06 1.08 1.23 1.13 1.03 1.08
KLA/ATP .95 1.00 .95 1.02 .97 1.04 1.04
Wnt16
KLA  ATP  ATP+KLA
 NM_053116 wingless-related MMTV integration site 16 (Wnt16), mRNA [NM_053116] KLA 1.00 1.02 .97 1.02 .96 1.02 1.05
ATP 1.01 1.00 .97 .98 .97 .95 1.02
KLA/ATP .96 1.01 .98 1.03 .99 1.00 .97
Wnt2
KLA  ATP  ATP+KLA
 NM_023653 wingless-related MMTV integration site 2 (Wnt2), mRNA [NM_023653] KLA 1.01 1.00 1.02 .96 1.06 1.03 .94
ATP .97 1.01 1.02 .98 1.00 1.05 1.01
KLA/ATP .97 .94 1.03 1.02 1.00 .99 1.05
Wnt2b
KLA  ATP  ATP+KLA
 NM_009520 wingless related MMTV integration site 2b (Wnt2b), mRNA [NM_009520] KLA 1.04 1.03 .99 1.01 .95 1.02 .99
ATP .95 1.00 .95 .99 .97 1.03 1.01
KLA/ATP 1.02 .99 1.01 1.06 .99 .99 1.02
Wnt3
KLA  ATP  ATP+KLA
 NM_009521 wingless-related MMTV integration site 3 (Wnt3), mRNA [NM_009521] KLA 1.04 1.02 1.04 1.02 1.00 .99 1.00
ATP 1.03 .98 1.04 1.04 .96 1.00 1.02
KLA/ATP 1.03 .99 .98 1.03 1.04 .94 1.03
Wnt3a
KLA  ATP  ATP+KLA
 NM_009522 wingless-related MMTV integration site 3A (Wnt3a), mRNA [NM_009522] KLA 1.01 1.00 1.06 1.02 .99 1.02 .99
ATP .96 .97 1.05 1.04 1.02 1.02 1.04
KLA/ATP 1.02 1.03 .96 1.01 .99 1.06 1.00
Wnt4
KLA  ATP  ATP+KLA
 NM_009523 wingless-related MMTV integration site 4 (Wnt4), mRNA [NM_009523] KLA 1.01 1.01 .97 1.06 1.12 1.02 .93
ATP 1.02 1.06 1.03 1.02 1.00 1.02 .98
KLA/ATP .94 1.01 1.06 1.05 .96 .96 1.00
Wnt5a
KLA  ATP  ATP+KLA
 NM_009524 wingless-related MMTV integration site 5A (Wnt5a), mRNA [NM_009524] KLA .98 1.06 1.01 .96 1.03 1.02 1.07
ATP 1.01 .96 1.06 1.11 1.02 .97 1.03
KLA/ATP 1.05 .96 .96 1.04 1.12 1.06 .96
Wnt5b
KLA  ATP  ATP+KLA
 NM_009525 wingless-related MMTV integration site 5B (Wnt5b), mRNA [NM_009525] KLA 1.04 1.04 1.19 1.11 1.10 1.11 1.05
ATP 1.04 1.01 .95 1.01 .99 1.04 1.05
KLA/ATP 1.05 1.06 1.11 1.07 1.04 1.08 1.05
Wnt6
KLA  ATP  ATP+KLA
 M89800 gb|Mouse Wnt-6 mRNA, complete cds. [M89800] KLA 1.92 1.97 1.93 2.04 2.01 2.62 5.22
ATP .96 .97 1.07 1.03 .76 .94 1.18
KLA/ATP 2.04 1.91 1.96 1.72 1.40 1.31 2.45
Wnt6
KLA  ATP  ATP+KLA
 NM_009526 wingless-related MMTV integration site 6 (Wnt6), mRNA [NM_009526] KLA 2.83 2.51 2.19 2.74 2.92 3.01 5.82
ATP 1.01 .87 1.07 .77 .59 1.11 1.06
KLA/ATP 2.31 2.49 2.69 1.79 1.63 1.26 2.64
Wnt7a
KLA  ATP  ATP+KLA
 NM_009527 wingless-related MMTV integration site 7A (Wnt7a), mRNA [NM_009527] KLA .96 .92 .91 .99 .96 .98 .97
ATP 1.05 .95 .98 .98 1.03 .98 1.11
KLA/ATP .92 .89 .88 .97 1.01 1.04 1.01
Wnt7b
KLA  ATP  ATP+KLA
 NM_009528 wingless-related MMTV integration site 7B (Wnt7b), mRNA [NM_009528] KLA 1.06 1.09 .99 1.09 1.06 1.19 1.26
ATP .99 .98 1.02 1.08 1.02 1.11 1.54
KLA/ATP 1.02 1.01 .99 1.14 1.07 1.09 1.58
Wnt8a
KLA  ATP  ATP+KLA
 NM_009290 wingless-related MMTV integration site 8A (Wnt8a), mRNA [NM_009290] KLA .92 1.01 .99 1.00 1.06 1.01 1.04
ATP 1.00 1.01 1.01 1.04 1.00 1.06 1.05
KLA/ATP 1.07 1.05 .99 1.08 1.07 1.09 1.07
Wnt8b
KLA  ATP  ATP+KLA
 NM_011720 wingless related MMTV integration site 8b (Wnt8b), mRNA [NM_011720] KLA 1.00 1.00 .94 1.03 .98 .98 .97
ATP .99 1.01 1.01 1.01 1.05 1.04 1.03
KLA/ATP .98 1.03 1.00 1.01 .99 1.02 1.02
Wnt9a
KLA  ATP  ATP+KLA
 NM_139298 wingless-type MMTV integration site 9A (Wnt9a), mRNA [NM_139298] KLA .93 .95 .95 1.01 .96 .97 1.01
ATP 1.01 .98 1.01 1.08 1.43 1.02 1.44
KLA/ATP .94 .96 1.03 1.15 1.43 1.15 1.21
Wnt9b
KLA  ATP  ATP+KLA
 NM_011719 wingless-type MMTV integration site 9B (Wnt9b), mRNA [NM_011719] KLA .97 1.00 .94 1.00 .99 .97 1.02
ATP .96 1.02 1.05 .99 .92 1.11 1.08
KLA/ATP .97 .96 .99 .93 .96 1.03 .99